InMed Pharmaceuticals Inc... (INM)
NASDAQ: INM
· Real-Time Price · USD
2.32
-0.02 (-0.85%)
At close: Aug 15, 2025, 3:59 PM
2.32
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT
InMed Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Cash & Equivalents | 4.68M | 3.42M | 5.58M | 6.57M | 7.6M | 9.53M | 6.74M | 8.91M | 9.6M | 11.45M | 9.35M | 6.18M | 5.9M | 11.28M | 15.34M | 7.36M | 9.45M | 10.02M | 4.5M |
Short-Term Investments | n/a | 40.79M | 43.2M | 43.06M | 43.09K | 44.46M | 42.94M | 44.42M | 43.05M | 43.05K | 42.13K | 44.8K | 46.1K | 45.42K | 45.22K | 46.46K | 45.77K | 45.23K | 43.16K |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 100K | 100K | 100M | 100K | 100K | 100K | 101.79K | 104.91K | 147.49K | 171.13K | 171.13K | 176.64K | -1.91M | 109.17K | 8.63K | 14.65K | 14.65K | 14.65K | 13.99K |
Receivables | 367.81K | 262.57K | 284.69M | 352.84K | 207.68K | 372.87K | 165.85K | 260.4K | 170.3K | 81.65K | 15.17K | 88.03K | 70.55K | 50.3K | 264.84K | 11.92K | 70.3K | 154.85K | 51.87K |
Inventory | 813.97K | 1.1M | 1.22B | 1.24M | 1.19M | 744.84K | 1.13M | 1.62M | 1.33M | 1.61M | 1.78M | 2.49M | 1.42M | 988.82K | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 548.45K | 684.77K | 148.88M | 477.75K | 1.02M | 1.16M | 257.96K | 542.46K | 738.26K | 826.93K | 42.13K | 44.8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 6.41M | 5.47M | 7.28B | 8.69M | 10.06M | 11.81M | 8.3M | 11.33M | 11.84M | 14.02M | 11.54M | 9.6M | 8.75M | 12.51M | 15.98M | 8.38M | 10.9M | 10.25M | 5.12M |
Property-Plant & Equipment | 1.11M | 1.23M | 1.34B | 1.25M | 1.37M | 1.48M | 615.05K | 723.43K | 753.24K | 703.92K | 802.37K | 904.25K | 1M | 1.1M | 304.93K | 326.6K | 347.89K | 373.84K | 384.53K |
Goodwill & Intangibles | 1.66M | 1.7M | 1.74B | 1.78M | 1.82M | 1.86M | 1.91M | 1.95M | 1.99M | 2.03M | 2.07M | 2.11M | 7.65M | 5.67M | 1.04M | 1.06M | 1.09M | 1.11M | 1.09M |
Total Long-Term Assets | 2.87M | 3.03M | 3.19B | 3.13M | 3.29M | 3.45M | 2.62M | 2.77M | 2.89M | 2.9M | 3.04M | 3.19M | 6.74M | 6.88M | 1.35M | 1.4M | 1.45M | 1.5M | 1.49M |
Total Assets | 9.28M | 8.5M | 10.47M | 11.82M | 13.36M | 15.26M | 10.92M | 14.11M | 14.73M | 16.92M | 14.58M | 12.79M | 15.49M | 19.38M | 17.33M | 9.78M | 12.35M | 11.75M | 6.6M |
Account Payables | 559.81K | 574.56K | 449K | 626.19K | 402.64K | 306.45K | 379.87K | 544.18K | 737.5K | 770.81K | 1.1M | 1.17M | 1.68M | 1.71M | 1.26M | 775.13K | 795.34K | 930.39K | 152.74K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | -1.68B | -1.34B | -2B | 16.17K | 16.17K | 15.7K | n/a | 8.9K | 8.39K | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 29.31K | 58.62K | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 464.67K | 1.79B | 1.43B | 539.54K | 205.03K | 450.88K | 279.56K | 558.48K | 708.81K | 403.72K | 249.59K | 139.12K | 711.42K | 447.7K | 273.15K | 880.21K | 582.5K | 552.66K | 655.14K |
Total Current Liabilities | 1.84M | 1.79B | 1.44B | 1.97M | 1.53M | 1.68M | 1.34M | 2M | 2.27M | 2.4M | 3.28M | 3.32M | 4.11M | 4.62M | 1.93M | 2.22M | 1.71M | 2.15M | 1.87M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.76M | n/a |
Total Long-Term Liabilities | 419.35K | 529.25K | 633.78K | 644.87K | 725.24K | 802.78K | n/a | 15.99K | 72.79K | 183.9K | 294.34K | 389.5K | 493.56K | 598.64K | 178.59K | 189.29K | 216.23K | 2M | 235.6K |
Total Liabilities | 2.26M | 2.32M | 2.07B | 2.62M | 2.25M | 2.48M | 1.34M | 2.02M | 2.34M | 2.58M | 3.58M | 3.71M | 4.6M | 5.22M | 2.11M | 2.4M | 1.93M | 4.16M | 2.11M |
Total Debt | 848.59K | 948.96K | 1.06M | 962.66K | 1.07M | 1.17M | 293K | 391.71K | 496.37K | 598.21K | 698.5K | 793.77K | 922.78K | 1.05M | 260.82K | 269.77K | 295.05K | 315.3K | 307K |
Common Stock | 87.46M | 84.54B | 84.2M | 82.78M | 80.61M | 79.94M | 77.62M | 77.62M | 77.62M | 74.86M | 72.67M | 70.72M | 69.83M | 69.1M | 63.69M | 60.59M | 60.59M | 58.01M | 53.07M |
Retained Earnings | -115.45M | -113.33B | -110.75M | -109.08M | -107.14M | -105.42M | -103.94M | -101.4M | -101.06M | -99.06M | -96.96M | -93.45M | -85.58M | -82.11M | -77.82M | -74.85M | -71.59M | -68.49M | -66.25M |
Comprehensive Income | 128.57K | 128.57K | 128.57K | 128.57K | 128.57K | 128.57K | 128.57K | 128.57K | 128.57K | 128.57K | 128.57K | 102.4M | 96.34M | 128.57K | 128.57K | 128.57K | 128.57K | 128.57K | -172.47K |
Shareholders Equity | 7.02M | 6.18B | 8.4M | 9.21M | 11.1M | 12.77M | 9.58M | 12.09M | 12.39M | 14.34M | 11.01M | 9.08M | 10.89M | 14.17M | 15.22M | 7.38M | 10.41M | 7.59M | 4.49M |
Total Investments | n/a | 40.79M | 43.2M | 43.06M | 43.09K | 44.46M | 42.94M | 44.42M | 43.05M | 43.05K | 42.13K | 44.8K | 46.1K | 45.42K | 45.22K | 46.46K | 45.77K | 45.23K | 43.16K |